Perrigo Company plc

US$15.85As of Sun 8 Nov 2026, 12:00 UTC
NYSE:PRGOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (12.66%)
Div yield 7.32%
ROE (50.25%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.69
PE TTM —
TSR TTM (16.37%)
Mkt cap US$2.200B
ROIC 4.09%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$20
25.01%
(63.20%)
Sell 0|2|1|1|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.32
0.32
0.35
0.39
11.26%
6.36%
12.19%
29.48%
Revenue$M
129.8
128.8
128.2
134.5
1.05%
1.99%
(3.77%)
1.66%
Peers (US$2.200B)
Cap (US$)
PE
7.713B
—
1.277B
—
Capital
TTM
5Y
10Y
Leveragex
4.063
0.031
0.030
EBIT/Intx
2.378
0.194
0.174
Own earn%
114.84
4.27
6.75
Sh yield%
16.83
35.95
36.09
Owners
Insiders/Inst%
8.04
61.33
Short interest%
4.09
SBC / revenue%
1.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
7